Artemis Health, a developer of non-invasive prenatal diagnostic tests, has appointed Richard Rava as its new senior vice president of R&D.
Subscribe to our email newsletter
Dr Rava comes to Artemis after 16 years at Affymetrix where he was a scientific co-founder and most recently senior vice president of R&D. Dr Rava has received his BA and PhD in chemistry from Rutgers University.
Lissa Goldenstein, president and CEO of Artemis Health, said: “Rich’s depth and breadth of research, development and manufacturing experience, together with his proven track record in commercializing genetic analysis tools, makes him uniquely suited to lead our efforts to bring non-invasive prenatal diagnostic tests to the market.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.